Co-Authors
This is a "connection" page, showing publications co-authored by Jason Cheng and Michael Drazer.
Connection Strength
0.279
-
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults. Blood Cancer J. 2025 Aug 14; 15(1):138.
Score: 0.058
-
ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance. Blood. 2025 Jul 10; 146(2):254-259.
Score: 0.058
-
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants. Leukemia. 2025 07; 39(7):1702-1713.
Score: 0.057
-
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 06 18; 14(1):99.
Score: 0.054
-
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults. Blood Adv. 2024 01 09; 8(1):164-171.
Score: 0.052